The oncometabolite D-2-hydroxyglutarate (2-HG) produced by mutant IDH is known to promote glioma genesis and to induce immunosuppressive effects in the tumor microenvironment (TME; refs. 10, 11). This evidence concerns the gene IDH1 and glioma.